Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors, Science, vol.267, pp.988-993, 1995. ,
Mechanisms of inhibition of HIV replication by nonnucleoside reverse transcriptase inhibitors, Virus Res, vol.134, pp.147-156, 2008. ,
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition, J. Mol. Biol, vol.385, pp.693-713, 2009. ,
The use of Highly Active Anti Retroviral Therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care and quality of life outcomes, J. Pain Symptom Manag, vol.21, pp.41-51, 2001. ,
, Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability, vol.16, pp.1-14, 2013.
Design, synthesis and in-vitro evaluation of novel tetrahydroquinolinecarbamates as HIV-1 RT inhibitor and their antifungal activity, Bioorg. Chem, vol.64, pp.66-73, 2016. ,
In vitro crossresistance profile of nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 against known NRTI resistance mutations, Antimicrob Agents Chemother, vol.57, pp.5500-5508, 2013. ,
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer non-nucleoside reverse transcriptase inhibitors, Antimicrob Agents Chemother, vol.59, pp.960-971, 2015. ,
Structural aspects of drug resistance and inhibition of HIV-1 reverse transcriptase, Viruses, vol.2, pp.606-638, 2010. ,
Resistance to reverse transcriptase inhibitors used in the treatment and prevention of HIV-1 infection, Future Microbiol, vol.10, pp.1773-1782, 2015. ,
High-resolution structures of HIV-1 reverse transcriptase/ TMC278 complexes: strategic flexibility explains potency against resistance mutations, Proc. Natl. Acad. Sci. USA, vol.105, pp.1466-1471, 2008. ,
Docking and scoring in virtual screening for drug discovery: methods and applications, Nat. Rev. Drug Discov, vol.3, pp.935-949, 2004. ,
Structure-based virtual screening for drug discovery: principles, applications and recent advances, Curr. Top Med. Chem, vol.14, pp.1923-1938, 2014. ,
Structure-based virtual ligand screening: recent success stories, Comb. Chem. High Throughput Screen, vol.12, pp.1000-1016, 2009. ,
Molecular docking and molecular dynamics simulation based approach to explore the dual inhibitor against HIV-1 reverse transcriptase and Integrase, Comb Chem High Throughput Screen, vol.20, 2017. ,
Computer tools in the discovery of HIV-I integrase inhibitors, Future Med. Chem, vol.2, pp.1123-1140, 2010. ,
Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays, J. Med. Chem, vol.55, pp.10108-10117, 2012. ,
Structure-based virtual screening and docking studies for the identification of novel inhibitors against wild and drug resistance strains of HIV-1 RT, Med. Chem. Res, vol.24, pp.1869-1883, 2015. ,
Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives, Bioorg. Chem, vol.72, pp.74-79, 2017. ,
Transcriptase inhibitors: lessons from the development of seven representative paradigms, J. Med. Chem, vol.55, pp.3595-3613, 2012. ,
Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl(4-chlorophenyl) amino)-1-(piperazin-1-yl)ethanone derivatives, Bioorg. Med. Chem. Lett, vol.27, pp.61-65, 2017. ,
HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design, Med. Res. Rev, vol.33, issue.1, pp.1-72, 2013. ,
De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors, Chem. Cent. J, vol.9, 2015. ,
5-chloro-3-(phenylsulfonyl)indole-2 carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase, J. Med. Chem, vol.36, pp.1291-1294, 1993. ,
Indolyl arylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide, J. Med. Chem, vol.54, pp.1587-1598, 2011. ,
Discovery of the aryl-phospho-indole IDX899, a highly potent anti-HIV Non-nucleoside reverse transcriptase inhibitor, J. Med. Chem, vol.59, pp.1891-1898, 2016. ,
inventors; Idenix Pharmaceuticals, Inc. assignee. Enatiomerically pure phosphoindoles as HIV inhibitors. United States patent, 2008. ,
Novel cyclopropyl-indole derivatives as HIV non-nucleoside reverse transcriptase inhibitors, ACS Med. Chem. Lett, vol.3, pp.470-475, 2012. ,
Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom, Antivir Chem. Chemother, vol.10, pp.285-314, 1999. ,
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains, Bioorg. Med. Chem. Lett, vol.17, pp.1956-1960, 2007. ,
Synthesis and in vitro antioxidant activity of new 3-substituted-2-oxindole derivatives, Indian J. Pharm. Sci, vol.74, pp.481-486, 2012. ,
An unprecedented protocol for the synthesis of 3-hydroxy-3-phenacyloxindole derivatives with indolin-2-ones and ?-substituted ketones, Org. Biomol. Chem, vol.14, pp.1395-1401, 2016. ,
mediated Henry reaction of isatins: an efficient synthesis of 3-hydroxy-2-oxindole, Green Chem. Lett. Rev, vol.6, pp.19-43, 2013. ,
Catalyst-free synthesis of 3-aryl-3-hydroxy-2-oxindole derivatives by using water as the solvent: experimental and DFT studies, Asian J. Org. Chem, vol.5, pp.1334-1344, 2016. ,
Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma, J. Med. Chem, vol.57, pp.10290-10303, 2014. ,
Non-isotopic assays of viral polymerases and related proteins, Methods Enzymol, vol.275, pp.257-276, 1996. ,
Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives, Bioorg. Chem, vol.67, pp.75-83, 2016. ,
Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity, FEBS Lett, vol.531, pp.295-298, 2002. ,
Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T lymphoid cells, Acta Pharmacol. Sin, vol.20, pp.239-243, 1999. ,
, , 2013.
Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design, J. Med. Chem, vol.53, pp.4295-4299, 2010. ,
Development and testing of the OPLS allatom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc, vol.118, pp.11225-11236, 1996. ,
, , 2013.